HHLR ADVISORS, LTD. - Q1 2022 holdings

$4.79 Billion is the total value of HHLR ADVISORS, LTD.'s 64 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 28.9% .

 Value Shares↓ Weighting
BGNE  BEIGENE LTDsponsored adr$1,032,068,000
-30.4%
5,472,2590.0%21.55%
-5.9%
JD BuyJD.COM INCspon adr cl a$488,103,000
+46.1%
8,434,471
+76.9%
10.19%
+97.5%
DASH BuyDOORDASH INCcl a$454,896,000
+135.7%
3,881,700
+199.4%
9.50%
+218.5%
CRM BuySALESFORCE COM INC$449,914,000
-8.3%
2,119,037
+9.8%
9.39%
+24.0%
LEGN SellLEGEND BIOTECH CORPsponsored ads$252,077,000
-54.2%
6,936,617
-41.2%
5.26%
-38.1%
SellON HLDG AGnamen akt a$234,732,000
-61.1%
9,300,000
-41.8%
4.90%
-47.5%
VIPS BuyVIPSHOP HOLDINGS LIMITEDsponsored ads a$199,354,000
+164.8%
22,150,493
+147.1%
4.16%
+257.9%
IQ  IQIYI INCsponsored ads$175,464,000
-0.4%
38,648,4770.0%3.66%
+34.5%
SE BuySEA LTDsponsord ads$174,091,000
-37.1%
1,453,300
+17.4%
3.64%
-15.0%
MDLZ  MONDELEZ INTL INCcl a$116,907,000
-5.3%
1,862,1640.0%2.44%
+27.9%
IMAB  I MABsponsored ads$116,649,000
-65.7%
7,182,8500.0%2.44%
-53.7%
 CYTEK BIOSCIENCES INC$94,401,000
-33.9%
8,757,0300.0%1.97%
-10.7%
DIDI NewDIDI GLOBAL INCsponsored ads$92,086,00036,834,320
+100.0%
1.92%
LI SellLI AUTO INCsponsored ads$64,436,000
-59.9%
2,496,550
-50.1%
1.34%
-45.8%
GOSS  GOSSAMER BIO INC$64,414,000
-23.3%
7,420,9740.0%1.34%
+3.7%
BEKE BuyKE HLDGS INCsponsored ads$64,106,000
-36.4%
5,182,364
+3.4%
1.34%
-14.1%
YMM NewFULL TRUCK ALLIANCE CO LTDsponsored ads$63,972,0009,590,942
+100.0%
1.34%
PLTK  PLAYTIKA HLDG CORP$63,416,000
+11.8%
3,280,6990.0%1.32%
+51.1%
 ENFUSION INCcl a$63,284,000
-39.3%
4,975,1830.0%1.32%
-18.0%
CPNG BuyCOUPANG INCcl a$59,235,000
-16.9%
3,350,400
+38.1%
1.24%
+12.4%
BBIO  BRIDGEBIO PHARMA INC$54,424,000
-39.1%
5,362,0140.0%1.14%
-17.8%
UBER  UBER TECHNOLOGIES INC$39,748,000
-14.9%
1,114,0000.0%0.83%
+15.0%
ARGX  ARGENX SEsponsored adr$37,837,000
-10.0%
120,0000.0%0.79%
+21.7%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$37,585,000
-13.3%
360,4950.0%0.78%
+17.2%
KNSA  KINIKSA PHARMACEUTICALS LTD$29,025,000
-15.5%
2,920,0230.0%0.61%
+14.1%
YSG  YATSEN HLDG LTDads$27,770,000
-68.1%
40,451,7130.0%0.58%
-56.8%
TIL  INSTIL BIO INC$25,644,000
-37.2%
2,385,4570.0%0.54%
-15.2%
AKRO  AKERO THERAPEUTICS INC$19,286,000
-32.9%
1,359,1520.0%0.40%
-9.2%
SNOW  SNOWFLAKE INCcl a$14,435,000
-32.4%
63,0000.0%0.30%
-8.8%
ACMR BuyACM RESH INC$13,878,000
-27.2%
670,755
+200.0%
0.29%
-1.7%
SOHU  SOHU COM LTDsponsored ads$13,490,000
+3.3%
802,0340.0%0.28%
+39.6%
MLCO  MELCO RESORTS AND ENTMNT LTDadr$12,979,000
-25.0%
1,698,8770.0%0.27%
+1.5%
FMTX  FORMA THERAPEUTICS HLDGS INC$10,230,000
-34.6%
1,100,0000.0%0.21%
-11.6%
HTHT SellHUAZHU GROUP LTDsponsored ads$10,003,000
-53.7%
303,200
-47.6%
0.21%
-37.4%
DYN  DYNE THERAPEUTICS INC$9,640,000
-18.9%
1,000,0000.0%0.20%
+9.2%
IPSC  CENTURY THERAPEUTICS INC$7,731,000
-20.6%
614,0950.0%0.16%
+7.3%
ADCT  ADC THERAPEUTICS SA$7,345,000
-27.3%
500,0000.0%0.15%
-1.9%
ALLO  ALLOGENE THERAPEUTICS INC$7,288,000
-38.9%
800,0000.0%0.15%
-17.4%
TALS SellTALARIS THERAPEUTICS INC$6,876,000
-41.0%
698,797
-8.3%
0.14%
-20.0%
SellTANGO THERAPEUTICS INC$6,686,000
-84.2%
882,088
-77.2%
0.14%
-78.6%
 HIPPO HLDGS INC$5,516,000
-29.7%
2,771,6910.0%0.12%
-5.0%
EM  SMART SH GLOBAL LTDads$5,263,000
-11.7%
4,080,0000.0%0.11%
+19.6%
ROOT  ROOT INC$5,122,000
-36.5%
2,600,0000.0%0.11%
-14.4%
ALGS  ALIGOS THERAPEUTICS INC$5,085,000
-81.9%
2,365,0640.0%0.11%
-75.6%
TUYA  TUYA INCsponsered ads$5,001,000
-52.6%
1,689,3590.0%0.10%
-36.2%
ZTO SellZTO EXPRESS CAYMAN INCsponsored ads a$5,000,000
-30.9%
200,000
-22.0%
0.10%
-7.1%
FUTU NewFUTU HLDGS LTDspon ads cl a$4,233,000130,000
+100.0%
0.09%
DQ NewDAQO NEW ENERGY CORPspnsrd ads new$4,132,000100,000
+100.0%
0.09%
PRLD  PRELUDE THERAPEUTICS INC$4,025,000
-44.6%
583,3330.0%0.08%
-25.0%
 SURROZEN INC$3,612,000
-53.3%
1,200,0000.0%0.08%
-37.0%
MREO  MEREO BIOPHARMA GROUP PLCads$3,333,000
-30.0%
2,976,1210.0%0.07%
-5.4%
PATH  UIPATH INCcl a$3,239,000
-49.9%
150,0000.0%0.07%
-32.0%
NewMOGU INCspon ads$3,064,000870,580
+100.0%
0.06%
 PYXIS ONCOLOGY INC$3,088,000
-63.2%
764,4060.0%0.06%
-50.8%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$2,391,000
-48.3%
3,985,7970.0%0.05%
-29.6%
UXIN  UXIN LTDads$2,343,000
-35.5%
2,297,3180.0%0.05%
-12.5%
 CCC INTELLIGENT SOLUTIONS HL$2,208,000
-3.1%
200,0000.0%0.05%
+31.4%
MNSO  MINISO GROUP HLDG LTDsponsored ads$1,968,000
-24.6%
252,3220.0%0.04%
+2.5%
SellTSCAN THERAPEUTICS INC$1,875,000
-67.5%
669,513
-47.8%
0.04%
-56.2%
 CHINA JO-JO DRUGSTORES INC$1,535,000
-15.5%
4,840,0000.0%0.03%
+14.3%
SFUN  FANG HLDGS LTDadr new$1,157,000
-7.4%
327,7200.0%0.02%
+26.3%
LEAPU  RIBBIT LEAP LTDunit 99/99/9999$498,000
+0.2%
50,0000.0%0.01%
+25.0%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$330,000
+13.4%
300,0000.0%0.01%
+75.0%
 SURROZEN INC*w exp 08/01/203$100,000
-78.3%
399,9990.0%0.00%
-71.4%
COIN ExitCOINBASE GLOBAL INC$0-10,000
-100.0%
-0.04%
DNUT ExitKRISPY KREME INC$0-188,638
-100.0%
-0.06%
MOGU ExitMOGU INCspon ads$0-10,446,970
-100.0%
-0.06%
DSGN ExitDESIGN THERAPEUTICS INC$0-280,991
-100.0%
-0.09%
RXDX ExitPROMETHEUS BIOSCIENCES INC$0-200,000
-100.0%
-0.12%
ExitRALLYBIO CORP$0-903,673
-100.0%
-0.13%
IMCR ExitIMMUNOCORE HLDGS PLCads$0-277,754
-100.0%
-0.15%
NIO ExitNIO INCspon ads$0-350,000
-100.0%
-0.17%
PDD ExitPINDUODUO INCsponsored ads$0-213,000
-100.0%
-0.19%
RGNX ExitREGENXBIO INC$0-456,000
-100.0%
-0.23%
BZ ExitKANZHUN LIMITEDsponsored ads$0-525,000
-100.0%
-0.28%
ABNB ExitAIRBNB INC$0-148,760
-100.0%
-0.38%
ExitMEMBERSHIP COLLECTIVE GROUP$0-2,009,509
-100.0%
-0.40%
XPEV ExitXPENG INCads$0-666,500
-100.0%
-0.52%
AMZN ExitAMAZON COM INC$0-15,000
-100.0%
-0.77%
AMG ExitAFFILIATED MANAGERS GROUP IN$0-335,073
-100.0%
-0.85%
ExitERASCA INC15.58$0-4,722,221
-100.0%
-1.14%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings